In Depth 18 May 2020 Will Covid-19 Change the Face of Vaccine Development? The unprecedented scale of the current Covid-19 pandemic has led to a vaccine ‘race’ the like of which has never been seen before. This may change the face of vaccine development forever. Since the English physician Edward Jenner invented the first smallpox vaccine in 1796, vaccines have resulted in dramatic reductions in deaths from previously […] May 18, 2020 - 13 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 14 May 2020 EU Initiative Pumps up Funding for Covid-19 Research to €117M The funding will go towards eight research projects that have been selected out of 144 proposals received by the EU’s Innovative Medicines Initiative. In March, the Innovative Medicines Initiative (IMI) opened a fast-track call for proposals on diagnostics and treatments for the coronavirus outbreak. Due to the large number of high-quality proposals received, the IMI […] May 14, 2020 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 May 2020 EU Pitches Into €7.4B Fund Supporting Covid-19 Treatments & Vaccines The European Commission and global donors have pledged €7.4 billion to a fund aimed at ensuring collaborative development and universal deployment of diagnostics, treatments, and vaccines for Covid-19. The Coronavirus Global Response pledging event is the beginning of a global fundraising marathon organized by the European Union and G20 nations in response to a World […] May 7, 2020 - 4 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
Expert Advice 4 May 2020 How Are Biotech VC Investments Changing with Covid-19? Covid-19 has been dominating the news for weeks on end, but what impact is the current pandemic having on biotech VC investments? Some key figures working in the field in Europe discussed their recent experiences, as well as advice for startups navigating this new funding challenge. The coronavirus pandemic has impacted us all in ways […] May 4, 2020 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2020 Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner Pfizer has become the first European mRNA vaccine for Covid-19 to enter human testing in a phase I/II trial. Since dosing began last week, twelve volunteers in Germany have been given the vaccine. The first part of the trial — […] April 29, 2020 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 24 Apr 2020 First Volunteers Dosed with European Coronavirus Vaccine The first European vaccine for coronavirus disease to enter clinical trials has been administered to UK volunteers in a project led by the University of Oxford. One volunteer was injected with the coronavirus vaccine and another with a control vaccine yesterday in a phase I trial that aims to recruit over 1,000 participants. The trial […] April 24, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 20 Apr 2020 How Has Coronavirus Affected Europe’s Biotech Stocks? The information flow about the coronavirus pandemic is truly electrifying, with big public market swings in the life sciences industry. That said, exactly what sort of impact is the disease known as Covid-19 having on biotech stocks? In the last few months, the Covid-19 pandemic situation has rocked the stock markets, causing intense swings across […] April 20, 2020 - 12 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
Expert Advice 13 Apr 2020 Need Funding to Fight Coronavirus? These Initiatives Have You Covered As coronavirus disease continues to take its devastating toll across the globe, there is a clear need for new strategies to curb it. Thankfully, initiatives are springing up around the world that can support European startups in the search for new methods of diagnosis, treatment, and prevention. Coronavirus disease, also known as Covid-19, is wreaking […] April 13, 2020 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2020 Coronavirus Pandemic Bites into European Cancer Research The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced cuts to payroll and research costs due to the coronavirus disease pandemic. Cancer Research UK is cutting research funding by €50M after calculating it will lose a quarter or more of its annual fundraising income — or €137m — through […] April 10, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2020 UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients The UK company Izana Bioscience is freely providing its phase III-ready anti-inflammatory antibody namilumab in a compassionate use program for the treatment of patients with coronavirus disease in Italy. In severe cases of coronavirus disease, also known as Covid-19, patients experience hyperinflammation. One of the drivers of inflammation is thought to be a protein called […] April 6, 2020 - 2 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
News and Trends 3 Apr 2020 UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection of 15,000 potential coronavirus disease treatments in collaboration with the US research institute Calibr and the non-profit synchrotron company Diamond Light Source. The team’s huge collection of drug molecules will be provided by Calibr, part of the US medical institute […] April 3, 2020 - 4 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
In Depth 30 Mar 2020 Could mRNA Vaccines Fulfill Their Potential Against Coronavirus? The first vaccine against coronavirus disease could one day be made of mRNA. How is mRNA showing promise against the pandemic, and what could it signify for the mRNA field? The global number of coronavirus disease (Covid-19) cases has passed 600,000 and is threatening to bring healthcare systems worldwide to their knees. To control the […] March 30, 2020 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email